InsidersTradesSigma
Follow the 苑东生物 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 苑东生物 has recorded 1 insider filings. Market capitalisation: €8.6bn. The latest transaction was reported on 28 July 2025 (Sale). Among the most active insiders: 成都楠苑投资合伙企业(有限合伙). Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
苑东生物 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of innovative drugs.